Aegis Capital 'Encouraged' by Initiation of Neuralstem's (CUR) NSI-566 Program; Affirms 'Buy' Rating
Tweet Send to a Friend
Aegis Capital affirms Neuralstem, Inc. (AMEX: CUR) at Buy with a price target of $7 following news that the first ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
